Business interview: CEO Murray Kessler talks Covid and sorting out Perrigo’s Irish tax bill
Dublin-domiciled group finally gets hold of MS drug revenue it initially pursed from Elan in 2013
US-based investor withdraws request for judicial review of Takeover Panel’s decision requiring it to lapse Elan offer
Outcome of special meeting in Dublin leaves sides effectively in stalemate
US pharma firm invited to bring forward “a new offer” following egm
Elan shareholders will today vote on a series of acquisitions
Elan shareholders to vote on transactions
How the Irish biotech firm got to this point and how the EGM may play out
Review of proxies suggests stalemate after four-month battle for control of company
Irish drug company seeking to fend off a hostile bid by US pharmaceutical investor Royalty Pharma
Majority of investors voted against proposals that stand in way of Royalty Pharma’s $6.7 billion bid
Court move means bid will not lapse pending full hearing even if shareholders back certain resolutions
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices